Ready, Set, Retina

GA Management: Patient Selection for Complement Inhibition Treatment

15 min · 20 de ago de 2025
Portada del episodio GA Management: Patient Selection for Complement Inhibition Treatment

Descripción

On this episode of Ready, Set, Retina, Daniel Epshtein, OD, FAAO, sits down with Murtaza Adam, MD, to review a case of geographic atrophy (GA) and discuss optimal patient selection for complement inhibition treatments. For the full episode including imaging, head to the article: https://eyesoneyecare.com/resources/ga-management-patient-selection-for-complement-inhibition-treatment Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Ready, Set, Retina!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

16 episodios

Portada del episodio Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO

Diabetic Re-Entry Retinopathy: Paul Chous, MA, OD, FAAO & Daniel Epshtein, OD, FAAO

On this episode of Ready, Set, Retina, Daniel Epshtein, OD, FAAO, is joined by A. Paul Chous, MA, OD, FAAO, to discuss a case report of diabetic re-entry retinopathy. Watch the full episode with imaging here: https://eyesoneyecare.com/resources/diabetic-re-entry-retinopathy Ready, Set, Retina is independently editorial content supported by advertising from Apellis Pharmaceuticals. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only. Ready Set Retina is independently editorial content supported by advertising from Astellas. The information provided in this article does not and is not intended to constitute medical advice; instead, all information, content, materials available herein are for general information purposes only.

22 de abr de 202516 min